[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.69, "open": 3.57, "dayLow": 3.5402, "dayHigh": 3.72, "regularMarketPreviousClose": 3.69, "regularMarketOpen": 3.57, "regularMarketDayLow": 3.5402, "regularMarketDayHigh": 3.72, "payoutRatio": 0.0, "beta": -0.357, "forwardPE": -2.6546764, "volume": 1104914, "regularMarketVolume": 1104914, "averageVolume": 1772645, "averageVolume10days": 1100080, "averageDailyVolume10Day": 1100080, "bid": 3.67, "ask": 3.73, "bidSize": 9, "askSize": 9, "marketCap": 313424544, "fiftyTwoWeekLow": 3.5402, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 4.8876, "twoHundredDayAverage": 6.796825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -58047624, "profitMargins": 0.0, "floatShares": 51342990, "sharesOutstanding": 84938896, "sharesShort": 5915984, "sharesShortPriorMonth": 7638295, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.069699995, "heldPercentInsiders": 0.00259, "heldPercentInstitutions": 1.0810701, "shortRatio": 3.29, "shortPercentOfFloat": 0.0766, "impliedSharesOutstanding": 84938896, "bookValue": 4.292, "priceToBook": 0.8597391, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -88073000, "trailingEps": -1.18, "forwardEps": -1.39, "enterpriseToEbitda": 0.582, "52WeekChange": -0.50403225, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 3.69, "targetHighPrice": 34.0, "targetLowPrice": 7.5, "targetMeanPrice": 19.0625, "targetMedianPrice": 19.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 372776992, "totalCashPerShare": 4.389, "ebitda": -99655000, "totalDebt": 1305000, "quickRatio": 32.665, "currentRatio": 32.992, "debtToEquity": 0.358, "returnOnAssets": -0.19229001, "returnOnEquity": -0.28279, "freeCashflow": -45897500, "operatingCashflow": -74748000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1740789211, "regularMarketTime": 1740776400, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 3.69, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 3.79403, "postMarketPrice": 3.83, "postMarketChange": 0.14, "regularMarketChange": 0.0, "regularMarketDayRange": "3.5402 - 3.72", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1772645, "fiftyTwoWeekLowChange": 0.14980006, "fiftyTwoWeekLowChangePercent": 0.04231401, "fiftyTwoWeekRange": "3.5402 - 11.4", "fiftyTwoWeekHighChange": -7.7099996, "fiftyTwoWeekHighChangePercent": -0.6763158, "fiftyTwoWeekChangePercent": -50.403225, "earningsTimestampStart": 1741777140, "earningsTimestampEnd": 1742212800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.18, "epsForward": -1.39, "epsCurrentYear": -1.19692, "priceEpsCurrentYear": -3.0829127, "fiftyDayAverageChange": -1.1975999, "fiftyDayAverageChangePercent": -0.24502821, "twoHundredDayAverageChange": -3.1068249, "twoHundredDayAverageChangePercent": -0.45709944, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]